Navigation Links
Roche Offers Innovative Website Designed to Empower Cancer Patients
Date:10/31/2007

-Interactive Online Resource Provides Customized Oral Chemotherapy

Information-

NUTLEY, N.J., Oct. 31 /PRNewswire/ -- Maximizing on the momentum gained during Breast Cancer Awareness Month, healthcare providers and advocacy organizations now have a helpful resource to offer cancer patients -- OralChemoAdvisor.com -- an educational, state-of-the-art Web site about oral chemotherapy. This straightforward, credible site is designed to help cancer patients and their family members make more informed healthcare decisions concerning oral chemotherapy treatment.

"There is a general lack of awareness about oral chemotherapy as a treatment option despite the overwhelming amount of resources dedicated to cancer patients," said Lars E. Birgerson, Vice President of Medical Affairs at Roche, which created and launched the site. "OralChemoAdvisor.com is specifically designed to help patients locate relevant information to help them better understand and assist in managing their treatment."

OralChemoAdvisor.com offers direct and easy access to a variety of educational tools designed to help patients who want to learn more about oral chemotherapy and its efficacy, risks and benefits. The site contains a unique video component that gives patients the option of interacting with oncology medical professionals and helps ensure that new information is retained. The expert videos include guides on oral chemotherapy treatment and patient-doctor communication, both of which also are available in written form. And, OralChemoAdvisor.com offers a list of oral chemotherapy treatments indicated for specific types of cancer, answers to frequently asked questions, and expert insights on cancer management and treatment.

"It is so important for breast cancer patients to have access to the most up-to-date information and resources. Web sites such as oralchemoadvisor.com are an important option for patients to help them make informed decisions about their individual course of treatment," stated Margaret C. Kirk, Chief Executive Officer, Y-ME National Breast Cancer Organization.

According to a recent survey conducted by Manhattan Research, CyberCitizen Health more than 14 million patients and caregivers went online in 2006 to gather information specific to oncology.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News and one of the Top 20 Employers (Science magazine). In 2006, Roche was ranked the No.1 Company to Sell For (Selling Power), and one of AARP's Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine's Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us


'/>"/>
SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Roche offers HIV drug expertise to poor nations
2. Roche Commits More Antiviral Pills To Asia For Bird Flu
3. FDA Imposes New Restrictions On Roches Accutane
4. Roche confirms Tamiflu production talks in US
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Roche Rolls Out Lung Cancer Drug In India
7. New Lung Cancer Drug Launched By Roche Pharmaceutical
8. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
9. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
10. NICE Gives the Final ‘NO’ to Roche’s Tarcva
11. Roche Announces Major Recall of HIV Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: